Published in Head Neck on July 22, 2010
Salivary gland carcinomas. Oral Maxillofac Surg (2012) 1.20
Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas. Br J Cancer (2013) 1.00
Genomic landscape of adenoid cystic carcinoma of the breast. J Pathol (2015) 0.93
Expression and function of CXCR4 in human salivary gland cancers. Clin Exp Metastasis (2012) 0.86
MicroRNA-101-3p suppresses cell proliferation, invasion and enhances chemotherapeutic sensitivity in salivary gland adenoid cystic carcinoma by targeting Pim-1. Am J Cancer Res (2015) 0.86
Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial. Br J Cancer (2013) 0.84
Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling. Oncotarget (2015) 0.83
Adenoid cystic carcinoma of the larynx: A report of two cases. Oncol Lett (2015) 0.83
Oncocytoma of the parotid gland: a case report and review of the literature. Case Rep Oncol (2014) 0.82
Adenoid cystic carcinoma of the buccal mucosa: a case report with review of literature. J Clin Diagn Res (2014) 0.80
Apigenin inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-1. Mol Med Rep (2015) 0.77
Tumour response following high-dose intratumoural application of Viscum album on a patient with adenoid cystic carcinoma. BMJ Case Rep (2014) 0.76
Lung metastases from cutaneous adenoid cystic carcinoma 23 years after initial treatment. Respir Med Case Rep (2017) 0.75
miR-98 functions as a tumor suppressor in salivary adenoid cystic carcinomas. Onco Targets Ther (2016) 0.75
Applications of molecular testing in surgical pathology of the head and neck. Mod Pathol (2017) 0.75
Adenoid cystic carcinoma of head and neck: A single institutional analysis of 66 patients treated with multi-modality approach. Indian J Med Paediatr Oncol (2016) 0.75
Pattern of recurrent disease in major salivary gland adenocystic carcinoma. Virchows Arch (2015) 0.75
A Phase II study of Dovitinib in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma. Clin Cancer Res (2017) 0.75
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med (2007) 7.05
The future of the TNM staging system in laryngeal cancer: time for a debate? Eur Arch Otorhinolaryngol (2008) 2.58
Paragangliomas of the head and neck. Oral Oncol (2004) 2.47
Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review. Laryngoscope (2014) 2.21
Analysis of pneumatization and neurovascular structures of the sphenoid sinus using cone-beam tomography (CBT). Acta Radiol (2012) 2.19
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck (2011) 1.97
CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res (2010) 1.97
Neuroendocrine neoplasms of the larynx: an overview. Head Neck (2009) 1.92
Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management. Oral Oncol (2006) 1.70
Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg (2008) 1.68
Thyroglossal duct cyst: personal experience and literature review. Auris Nasus Larynx (2007) 1.57
Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol (2012) 1.55
Treatment with ozone/oxygen-pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas. Int J Cancer (2008) 1.51
Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhinolaryngol (2010) 1.48
Sinonasal tumors: a clinicopathologic update of selected tumors. Eur Arch Otorhinolaryngol (2012) 1.43
Effectiveness of radiochemotherapy on lymph node metastases in patients with stage IV oropharyngeal cancer. Oral Oncol (2004) 1.42
An outline of the history of head and neck oncology. Oral Oncol (2007) 1.42
Update on hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol (2008) 1.39
Do pathologic and molecular analyses of neck dissection specimens justify the preservation of level IV for laryngeal squamous carcinoma with clinically negative neck? J Am Coll Surg (2005) 1.39
Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes. Oral Oncol (2002) 1.38
Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin Cancer Res (2007) 1.37
Aspergillosis--and a misleading sensitivity result. Lancet (2007) 1.36
Pathogenesis of lymphangiomas. Virchows Arch (2008) 1.35
Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence. Head Neck (2010) 1.34
Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck (2010) 1.34
Advances and applications of oral cancer basic research. Oral Oncol (2011) 1.33
Management of sarcomas of the head and neck in adults. Oral Oncol (2003) 1.31
Evidence-based review of treatment options for patients with glottic cancer. Head Neck (2011) 1.30
Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol (2009) 1.29
Neck disease and distant metastases. Oral Oncol (2003) 1.27
Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice. Oral Oncol (2010) 1.26
Elective and therapeutic selective neck dissection. Oral Oncol (2005) 1.26
Human papillomavirus infections in laryngeal cancer. Head Neck (2011) 1.22
Surgical margins in head and neck cancer: a contemporary review. Head Neck (2012) 1.19
Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer. Head Neck (2008) 1.18
Esthesioneuroblastoma and cervical lymph node metastases: clinical and therapeutic implications. Acta Otolaryngol (2002) 1.16
Management of nasal bone fractures. Am J Otolaryngol (2005) 1.16
Neck dissection: then and now. Auris Nasus Larynx (2006) 1.14
A meta-analysis of the randomized controlled trials on elective neck dissection versus therapeutic neck dissection in oral cavity cancers with clinically node-negative neck. Oral Oncol (2011) 1.14
Aggressive variants of papillary thyroid carcinoma. Head Neck (2010) 1.13
Routine drainage after thyroid surgery--a meta-analysis. J Surg Oncol (2007) 1.13
Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. Head Neck (2011) 1.13
Jugular and vagal paragangliomas: Systematic study of management with surgery and radiotherapy. Head Neck (2012) 1.13
Cutaneous squamous cell carcinoma of the head and neck metastasizing to the parotid gland--a review of current recommendations. Head Neck (2010) 1.12
Cutaneous manifestation of myiasis in malignant wounds of the head and neck. Eur J Dermatol (2008) 1.12
Management of malignant sublingual salivary gland tumors. Oral Oncol (2004) 1.11